135 related articles for article (PubMed ID: 37502593)
1. Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
Markers D
Dis Markers; 2023; 2023():9781753. PubMed ID: 37502593
[TBL] [Abstract][Full Text] [Related]
2. The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
Jin X; Sun ZQ; Zhou GL; Li GJ; Deng SF
Dis Markers; 2022; 2022():2184867. PubMed ID: 35386230
[TBL] [Abstract][Full Text] [Related]
3. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
Tang M; Liao M; Ai X; He G
Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Knockdown of lncRNA
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9859158. PubMed ID: 37501828
[TBL] [Abstract][Full Text] [Related]
5. Retracted: KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9856509. PubMed ID: 37810558
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
[TBL] [Abstract][Full Text] [Related]
7. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
[TBL] [Abstract][Full Text] [Related]
10. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Yu Z; Zhang Y; Shao S; Liu Q; Li Y; Du X; Zhang K; Zhang M; Yuan H; Yuan Q; Liu T; Gao Y; Wang Y; Hong W; Han T
Front Oncol; 2021; 11():755814. PubMed ID: 34660326
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
[TBL] [Abstract][Full Text] [Related]
12. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
13. Retracted: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9801756. PubMed ID: 37593684
[TBL] [Abstract][Full Text] [Related]
14. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
Li K; Fan T; Shi Z; Jiang H
Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer.
Markers D
Dis Markers; 2023; 2023():9898020. PubMed ID: 37502572
[TBL] [Abstract][Full Text] [Related]
16. CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway.
Zhang Y; Cheng Y; Zhang Z; Bai Z; Jin H; Guo X; Huang X; Li M; Wang M; Shu XS; Yuan Y; Ying Y
Front Oncol; 2020; 10():725. PubMed ID: 32509575
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Abnormal COX2 Protein Expression May Be Correlated with Poor Prognosis in Oral Cancer: A Meta-Analysis.
International BR
Biomed Res Int; 2021; 2021():3284807. PubMed ID: 33681352
[TBL] [Abstract][Full Text] [Related]
18. Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9876457. PubMed ID: 37387918
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9891861. PubMed ID: 37621613
[TBL] [Abstract][Full Text] [Related]
20. Retracted: HDAC2 Induces DNA Methyltransferase DNMT3B Expression to Regulate the Wnt Signaling Pathway and Thus Promotes Glioma Development and Progression.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9864167. PubMed ID: 37593015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
